
Sign up to save your podcasts
Or


In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
By Jeffrey S. Guy, MD, FACS4.8
649649 ratings
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.

63,671 Listeners

11,352 Listeners

1,081 Listeners

1,868 Listeners

322 Listeners

946 Listeners

3,907 Listeners

898 Listeners

2,875 Listeners

1,541 Listeners

260 Listeners

8,280 Listeners

402 Listeners

249 Listeners

233 Listeners